Receptor Activity-Modifying Proteins (RAMPs): New Insights and Roles

被引:128
|
作者
Hay, Debbie L. [1 ,2 ]
Pioszak, Augen A. [3 ]
机构
[1] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand
[2] Univ Auckland, Maurice Wilkins Ctr, Auckland 1142, New Zealand
[3] Univ Oklahoma, Hlth Sci Ctr, Dept Biochem & Mol Biol, Oklahoma City, OK 73104 USA
来源
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 56 | 2016年 / 56卷
关键词
adrenomedullin; amylin; CGRP; calcium-sensing receptor; CRF; GPR30; heterodimer; GPCR; RAMP; VIP; GENE-RELATED PEPTIDE; CORTICOTROPIN-RELEASING-FACTOR; CLASS-B GPCR; CALCITONIN-RECEPTOR; COUPLED-RECEPTOR; EXTRACELLULAR DOMAIN; CGRP-RECEPTOR; ADRENOMEDULLIN RECEPTOR; CRYSTAL-STRUCTURE; DIFFERENTIALLY MODULATE;
D O I
10.1146/annurev-pharmtox-010715-103120
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
It is now recognized that G protein-coupled receptors (GPCRs), once considered largely independent functional units, have a far more diverse molecular architecture. Receptor activity-modifying proteins (RAMPs) provide an important example of proteins that interact with GPCRs to modify their function. RAMPsare able to act as pharmacological switches and chaperones, and they can regulate signaling and/or trafficking in a receptor-dependent manner. This review covers recent discoveries in the RAMP field and summarizes the knownGPCRpartners and functions of RAMPs. Wealso discuss the first peptide-bound structures of RAMP-GPCR complexes, which give insight into the molecular mechanisms that enable RAMPs to alter the pharmacology and signaling of GPCRs.
引用
收藏
页码:469 / 487
页数:19
相关论文
共 50 条
  • [41] Novel calcitonin-(8-32)-sensitive adrenomedullin receptors derived from co-expression of calcitonin receptor with receptor activity-modifying proteins
    Kuwasako, K
    Kitamura, K
    Nagoshi, Y
    Eto, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 301 (02) : 460 - 464
  • [42] Receptor activity-modifying protein modulation of parathyroid hormone-1 receptor function and signaling
    Avgoustou, Paris
    Jailani, Ameera B. A.
    Desai, Aditya J.
    Roberts, David J.
    Lilley, Ewan R.
    Stothard, Grant W.
    Skerry, Timothy M.
    Richards, Gareth O.
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [43] Neuronal Receptor Activity-Modifying Protein 1 Promotes Energy Expenditure in Mice
    Zhang, Zhongming
    Liu, Xuebo
    Morgan, Donald A.
    Kuburas, Adisa
    Thedens, Daniel R.
    Russo, Andrew F.
    Rahmouni, Kamal
    DIABETES, 2011, 60 (04) : 1063 - 1071
  • [44] Receptor activity-modifying protein 1 regulates the phenotypic expression of BMSCs via the Hippo/Yap pathway
    Zhang, Qin
    Guo, Yanjun
    Yu, Hui
    Tang, Yufei
    Yuan, Ying
    Jiang, Yixuan
    Chen, Huilu
    Gong, Ping
    Xiang, Lin
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (08) : 13969 - 13976
  • [45] Receptor Activity-Modifying Protein 2 (RAMP2) alters glucagon receptor trafficking in hepatocytes with functional effects on receptor signalling
    McGlone, Emma Rose
    Manchanda, Yusman
    Jones, Ben
    Pickford, Phil
    Inoue, Asuka
    Carling, David
    Bloom, Stephen R.
    Tan, Tricia
    Tomas, Alejandra
    MOLECULAR METABOLISM, 2021, 53
  • [46] The Impact of Adrenomedullin Thr22 on Selectivity within the Calcitonin Receptor-like Receptor/Receptor Activity-Modifying Protein System
    Fischer, Jan-Patrick
    Els-Heindl, Sylvia
    Schoenauer, Ria
    Bierer, Donald
    Koebberling, Johannes
    Riedl, Bernd
    Beck-Sickinger, Annette G.
    CHEMMEDCHEM, 2018, 13 (17) : 1797 - 1805
  • [47] Inhibition of receptor activity-modifying protein 1 suppresses the development of endometriosis and the formation of blood and lymphatic vessels
    Honda, Masako
    Ito, Yoshiya
    Hattori, Kyoko
    Hosono, Kanako
    Sekiguchi, Kazuki
    Tsujikawa, Kazutake
    Unno, Nobuya
    Majima, Masataka
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2020, 24 (20) : 11984 - 11997
  • [48] Receptor activity-modifying protein dependent and independent activation mechanisms in the coupling of calcitonin gene-related peptide and adrenomedullin receptors to Gs
    Woolley, Michael J.
    Reynolds, Christopher A.
    Simms, John
    Walker, Christopher S.
    Mobarec, Juan Carlos
    Garelja, Michael L.
    Conner, Alex C.
    Poyner, David R.
    Hay, Debbie L.
    BIOCHEMICAL PHARMACOLOGY, 2017, 142 : 96 - 110
  • [49] Increased receptor activity-modifying protein 1 in the nervous system is sufficient to protect against autonomic dysregulation and hypertension
    Sabharwal, Rasna
    Mason, Bianca N.
    Kuburas, Adisa
    Abboud, Francois M.
    Russo, Andrew F.
    Chapleau, Mark W.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2019, 39 (04): : 690 - 703
  • [50] Characterization of the single transmembrane domain of human receptor activity-modifying protein 3 in adrenomedullin receptor internalization
    Kuwasako, Kenji
    Kitamura, Kazuo
    Nagata, Sayaka
    Nozaki, Naomi
    Kato, Johji
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 420 (03) : 582 - 587